Picture of Cytosorbents logo

CTSO Cytosorbents News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: CytoSorbents Reports Preliminary Fourth Quarter And Full Year 2022 Revenue

Jan 31 (Reuters) - Cytosorbents Corp  CTSO.O :
    * CYTOSORBENTS ISSUES STOCKHOLDER LETTER AND REPORTS
PRELIMINARY
FOURTH QUARTER AND FULL YEAR 2022 REVENUE
    * CYTOSORBENTS CORP - Q4 2022 PRODUCT SALES REBOUNDED FROM
Q3 2022
LOW
    * CYTOSORBENTS CORP - ADJUSTED FOR CONSTANT CURRENCY, CORE
NON-COVID 2022 PRODUCT SALES WERE WITHIN 5% OF THAT ACHIEVED IN
2021
    * CYTOSORBENTS CORP - Q4 2022 TOTAL REVENUE WAS
APPROXIMATELY $9.4
MILLION VERSUS $10.8 MILLION IN Q4 2021

Source text for Eikon:  ID:nPn3bmzSMa 
Further company coverage:  CTSO.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cytosorbents

See all news